Evidence map›Paper›PMID 27980421›Full record

ArticleNutrition and metabolic insights2016

A Mouse Model of Diet-Induced Obesity Resembling Most Features of Human Metabolic Syndrome.

Maria C Della Vedova, Marcos D Muñoz, Lucas D Santillan, Maria G Plateo-Pignatari, Maria J Germanó, Martín E Rinaldi Tosi, Silvina Garcia, Nidia N Gomez, Miguel W Fornes, Sandra E Gomez Mejiba and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrition and metabolic insights, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Selective and differential roles of PVHNature communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Foods (Basel, Switzerland) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maria C Della VedovaLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.; Laboratory of Experimental Therapeutics, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Marcos D MuñozLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Lucas D SantillanLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.; Laboratory of Experimental Therapeutics, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.; Institute for Biochemical Research (INBIO), San Luis, Argentina.
Maria G Plateo-PignatariLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Maria J GermanóLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Martín E Rinaldi TosiLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Silvina GarciaLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Nidia N GomezLaboratory of Morphophysiology, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Miguel W FornesLIAM, Andrology Research Laboratory from Mendoza, IHEM-CCT-Mendoza-National University of Cuyo, Mendoza, Argentina.
Sandra E Gomez MejibaLaboratory of Experimental Therapeutics, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Dario C RamirezLaboratory of Experimental and Translational Medicine, IMIBIO-SL, CONICET, National University of San Luis, San Luis, Argentina.
Centro Científico Tecnológico - San Luis · ARUniversity of Mendoza · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased chicken-derived fat and fructose consumption in the human diet is paralleled by an increasing prevalence of obesity and metabolic syndrome (MS). Herein, we aimed at developing and characterizing a mouse model of diet-induced obesity (DIO) resembling most of the key features of the human MS. To accomplish this, we fed male C57BL/6J mice for 4, 8, 12, and 16 weeks with either a low-fat diet (LFD) or a high-chicken-fat diet (HFD) and tap water with or without 10% fructose (F). This experimental design resulted in the following four experimental groups: LFD, LFD + F, HFD, and HFD + F. Over the feeding period, and on a weekly basis, the HFD + F group had more caloric intake and gained more weight than the other experimental groups. Compared to the other groups, and at the end of the feeding period, the HFD + F group had a higher adipogenic index, total cholesterol, low-density lipoprotein cholesterol, fasting basal glycemia, insulin resistance, hypertension, and atherogenic index and showed steatohepatitis and systemic oxidative stress/inflammation. A mouse model of DIO that will allow us to study the effect of MS in different organs and systems has been developed and characterized.

Indexed as

adipositydiet-induced obesityinflammationmetabolic syndromemouse modelredox change

Identifiers

PMID27980421
PMCPMC5140012
OpenAlexW2560347556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.